Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+7.21%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$93.6B
AUM Growth
+$11.5B
(+14%)
Cap. Flow
+$6.53B
Cap. Flow
% of AUM
6.98%
Top 10 Holdings %
Top 10 Hldgs %
30.05%
Holding
1,605
New
33
Increased
702
Reduced
242
Closed
12
Top Buys
| 1 |
CME Group
CME
|
+$546M |
| 2 |
Apple
AAPL
|
+$519M |
| 3 |
Booking.com
BKNG
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$401M |
| 5 |
AutoZone
AZO
|
+$325M |
Top Sells
| 1 |
Danaher
DHR
|
+$369M |
| 2 |
Moody's
MCO
|
+$173M |
| 3 |
Philip Morris
PM
|
+$160M |
| 4 |
Accenture
ACN
|
+$140M |
| 5 |
Equifax
EFX
|
+$131M |
Sector Composition
| 1 | Technology | 30.78% |
| 2 | Financials | 14.09% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 9.66% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Ionis Pharmaceuticals
IONS
$10.1B
| $224K | ﹤0.01% |
5,585
-489
| -8% | -$19.6K |
|
952
Novavax
NVAX
$1.3B
| $223K | ﹤0.01% |
17,645
-1,666
| -9% | -$21K |
|
953
Sanofi
SNY
$115B
| $223K | ﹤0.01% |
3,867
-464
| -11% | -$26.7K |
|
954
Rocket Pharmaceuticals
RCKT
$347M
| $222K | ﹤0.01% |
12,006
-1,112
| -8% | -$20.5K |
|
955
Novartis
NVS
$244B
| $217K | ﹤0.01% |
1,884
-177
| -9% | -$20.4K |
|
956
Shopify
SHOP
$187B
| $216K | ﹤0.01% |
2,694
-67
| -2% | -$5.37K |
|
957
Intellia Therapeutics
NTLA
$1.25B
| $212K | ﹤0.01% |
10,321
-966
| -9% | -$19.9K |
|
958
CVRx
CVRX
$209M
| $211K | ﹤0.01% |
23,937
-872
| -4% | -$7.68K |
|
959
Immatics
IMTX
$728M
| $208K | ﹤0.01% |
18,224
-1,720
| -9% | -$19.6K |
|
960
Arrowhead Research
ARWR
$3.94B
| $208K | ﹤0.01% |
10,725
-993
| -8% | -$19.2K |
|
961
Arcturus Therapeutics
ARCT
$476M
| $205K | ﹤0.01% |
8,814
-832
| -9% | -$19.3K |
|
962
Graham Corp
GHM
$525M
| $202K | ﹤0.01% |
6,833
+327
| +5% | +$9.68K |
|
963
Lufax Holding
LU
$2.58B
| $200K | ﹤0.01% |
57,328
-1,422
| -2% | -$4.96K |
|
964
Tango Therapeutics
TNGX
$724M
| $200K | ﹤0.01% |
25,934
-2,446
| -9% | -$18.8K |
|
965
Maravai LifeSciences
MRVI
$378M
| $200K | ﹤0.01% |
24,028
-2,266
| -9% | -$18.8K |
|
966
Roivant Sciences
ROIV
$9.32B
| $199K | ﹤0.01% |
17,250
-1,628
| -9% | -$18.8K |
|
967
Paysafe
PSFE
$829M
| $199K | ﹤0.01% |
8,863
-220
| -2% | -$4.94K |
|
968
Alphatec Holdings
ATEC
$2.32B
| $198K | ﹤0.01% |
35,606
+673
| +2% | +$3.74K |
|
969
Box
BOX
$4.75B
| $193K | ﹤0.01% |
5,900
| – | – |
|
970
Vir Biotechnology
VIR
$718M
| $193K | ﹤0.01% |
25,770
-2,430
| -9% | -$18.2K |
|
971
Azenta
AZTA
$1.35B
| $187K | ﹤0.01% |
3,870
-355
| -8% | -$17.2K |
|
972
dLocal
DLO
$4.12B
| $184K | ﹤0.01% |
22,966
-570
| -2% | -$4.56K |
|
|
NVEI
973
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $183K | ﹤0.01% |
5,484
-136
| -2% | -$4.54K |
|
974
Paymentus
PAY
$4.47B
| $182K | ﹤0.01% |
9,068
-225
| -2% | -$4.5K |
|
975
Regenxbio
RGNX
$502M
| $180K | ﹤0.01% |
17,163
-1,619
| -9% | -$17K |
|